Worldwide pharma industry sales force levels flat in 2014
Pharma industry sales force levels in 2014 showed a slowdown in the decline seen in previous years, according to market research company Cegedim Strategic Data (CSD).
Worldwide, sales force levels were flat at 439,500 full time rep equivalents (FTEs) – a slight +0.4% increase compared to 2013. North America sales force levels continue to decrease, however, at a slower rate, where total FTEs stood at just under 65,000 representing a decline of 2%. Overall, FTE estimates for the top five European countries (France, Germany, Italy, UK and Spain) showed a decrease of 5.3% to 72,000 reps. However, of these top five countries, the UK maintained stable sales force levels in 2014 (+0.5%) compared to a 12% drop in 2013.
China and Brazil show some growth
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze